KYMR vs JNJ: Which Stock is Better?
Side-by-side comparison of Kymera Therapeutics Inc and Johnson & Johnson in 2026
KYMR
Kymera Therapeutics Inc
—
JNJ
Johnson & Johnson
$263.40
Key Metrics Comparison
| Metric | KYMR | JNJ | Winner |
|---|---|---|---|
| Market Cap | $7.39B | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze KYMR
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYMR or JNJ a better investment?
Comparing KYMR and JNJ: Kymera Therapeutics Inc has a market cap of $7.39B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYMR and JNJ?
KYMR (Kymera Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYMR or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KYMR or JNJ?
Both KYMR and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: KYMR or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: KYMR or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $7.39B for KYMR.
Should I buy KYMR or JNJ in 2026?
Both KYMR and JNJ have investment merit. KYMR trades at $N/A while JNJ trades at $263.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYMR and JNJ stock?
Key differences: Market Cap ($7.39B vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy KYMR or JNJ in 2026?
The choice between KYMR and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KYMR and JNJ?
KYMR (Kymera Therapeutics Inc) has a market cap of $7.39B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.